Tirupati Group
Tirupati Group is a pharmaceutical and nutraceutical CDMO founded in 2005, providing contract manufacturing, formulation development, and private label solutions across tablets, capsules, liquids, and topical dosage forms to 350+ healthcare companies globally from facilities in Himachal Pradesh and Noida, India.
- Company typePrivate
- Founded2005
- HeadquartersNew Delhi, India
- Headcount1,001–5,000
- GTM typeB2B
- OfferingHardware or Manufacturing
What Tirupati Group does
Tirupati Group is a pharmaceutical and nutraceutical Contract Development and Manufacturing Organization (CDMO) founded in 2005 and headquartered in New Delhi, India. The group provides end-to-end contract manufacturing, product development, and private label solutions across six business verticals: pharmaceuticals, therapeutics, nutraceuticals, Ayurveda, sports nutrition, and veterinary products, serving 350+ companies globally including 75+ reputed international clients. Operations span multi-location manufacturing facilities in Paonta Sahib (Himachal Pradesh) and Noida (Uttar Pradesh) with a dosage-form portfolio covering tablets, capsules, oral liquids, powders, nasal/ear/eye drops, creams, ointments, and oils, supported by annual capacity of 140+ Crore tablets, 345+ Crore capsules, and 35,900+ units of liquids and powders. The group's technology and regulatory infrastructure includes a DSIR-approved R&D centre (TRDC) for formulation development, regulatory affairs capability for ACTD/CTD/eCTD submissions, and 25+ international certifications including WHO GMP, US FDA registration, EU Certificate of Conformity, Health Canada, MFDS Korea, and AYUSH Premium Mark. The group operates through five entities: Tirupati Medicare Limited (parent), Tirupati Lifesciences, Tirupati Wellness, Newtramax Healthcare, and the recently acquired Surya Herbal Limited.
Tirupati operates a B2B contract manufacturing and private-label model, generating revenue through per-batch manufacturing fees, formulation development charges, and private-label supply agreements. Pricing is quote-based and varies by dosage form, volume, regulatory jurisdiction, and certification requirements. Distribution is sales-led with an export presence in 10+ countries including the Philippines, UAE, USA, Canada, Korea, China, EU nations, Nepal, Yemen, and Uganda. The company is family-controlled by the Goyal family and has received two rounds of private equity investment: $50M from Affirma Capital in 2019 and approximately $122.5M from Kotak Alternate Asset Managers in March 2025. Tirupati reached a 1000+ Crore INR revenue milestone by 2023, equivalent to approximately $120M USD, reflecting a reported trajectory from 300+ Crore INR (2014) to 500+ Crore INR (2018) to 1000+ Crore INR (2023).
Tirupati Group firmographics
Firmographics- Name
- Tirupati Group
- Legal name
- TIRUPATI MEDICARE LIMITED
- Website
- https://tirupatigroup.co.in
- Company type
- Private
- Founded year
- 2005
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Short description
- Tirupati Group is a pharmaceutical and nutraceutical CDMO founded in 2005, providing contract manufacturing, formulation development, and private label solutions across tablets, capsules, liquids, and topical dosage forms to 350+ healthcare companies globally from facilities in Himachal Pradesh and Noida, India.
- Ownership category
- akta.pro rank
Tirupati Group industry classification
Industry- Product category
- Pharmaceutical Contract Manufacturing
- NAICS
- Pharmaceutical and Medicine Manufacturing (3254), Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO (HLAGABAB)
- akta.pro secondary industries
- Sterile Fill-Finish & Aseptic Manufacturing CDMO (HLAGABAH), Contract Development & Manufacturing for Generics (CDMO/CMO) (HLAIABAI), Drug Substance–Drug Product Integrated CDMO (HLAGABAG), Specialty Condition Supplements (Sleep, Stress, Heart, Joint, Gut, Immunity) (CRADAGAE)
Keywords
Where Tirupati Group is headquartered
LocationHeadquarters
- HQ city
- New Delhi
- HQ country
- India
- HQ region
- Asia
Offices4 records
Markets served
Tirupati Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Contract Manufacturing: Manufacturing partner providing end-to-end support from concept development to commercial production for pharmaceutical, nutraceutical, Ayurveda, and wellness products. Revenue generated through manufacturing fees based on production volume and complexity.
- Product Development Services: R&D and product development services including new formulations, stability testing, and product differentiation for partners seeking customized healthcare solutions.
- Private Label Solutions: Manufacturing under partner brands with flexible solutions for different product formats including strips, blisters, sachets, pouches, tubes, jars, and roll-ons.
Go-to-market motion1 record
Distribution channels2 records
Marketing channels2 records
Tirupati Group product offering
Product offeringCore offering
Tirupati Group is a Contract Development and Manufacturing Organization (CDMO) that provides end-to-end pharmaceutical and nutraceutical manufacturing services to healthcare brands. The company delivers integrated solutions spanning concept development, formulation R&D, regulatory support, and commercial-scale production across multiple dosage forms (tablets, capsules, oral liquids, powders, drops, creams, ointments, and oils) for pharmaceutical, nutraceutical, Ayurveda, sports nutrition, and veterinary segments. Services include contract manufacturing, product development, private label solutions, and commercial scale production for 350+ partner companies globally.
Product overview
Tirupati Group operates as a Contract Development and Manufacturing Organization (CDMO) providing integrated pharmaceutical and nutraceutical manufacturing services. The company offers end-to-end solutions from concept development to commercial production across six business verticals: Pharmaceuticals (contract manufacturing), Therapeutics, Nutraceuticals, Ayurveda, Sports Nutrition, and Veterinary products. The portfolio includes multiple dosage form capabilities (tablets, capsules, oral liquids, powders, drops, creams, ointments, oils) manufactured through five group companies: Tirupati Medicare Limited (pharmaceutical formulations), Tirupati Lifesciences Private Limited (nutraceuticals and wellness), Tirupati Wellness Private Limited (innovative nutraceuticals), Surya Herbal Limited (acquired Ayurvedic/herbal products), and Newtramax Healthcare. The company emphasizes integrated development and manufacturing with multi-dosage expertise, strong regulatory compliance systems, and scalable production capacity for domestic and global markets.
Differentiator
Problem solved
Functional benefit
Brands
- Surya Herbal: Ayurvedic and herbal product manufacturing brand acquired in 2024
- TRDC (Tirupati Research and Development Centre)
Products and services
- Pharmaceutical Contract Manufacturing End-to-end pharmaceutical contract manufacturing services from concept development to commercial production, serving as a CDMO partner for pharmaceutical brands.
- Therapeutics Contract Manufacturing Development and manufacturing of therapeutic products designed for reliability and scale, supporting pharmaceutical brand partners with generic and prescription medications.
- Nutraceutical Contract Manufacturing Science-backed nutraceutical solutions focused on preventive health and evolving lifestyle needs, manufactured at scale with NSF-GMP certified facilities for dietary supplement and functional food brands.
- Ayurveda Contract Manufacturing Ayurvedic and herbal product manufacturing combining traditional knowledge with modern processes, supported by AYUSH Premium Mark and Ayurvedic WHO GMP certifications for traditional medicine brands.
- Sports Nutrition Contract Manufacturing High-quality sports and performance nutrition formulations built for modern wellness and fitness brands, with flexible formats and rapid scale-up capabilities.
- Veterinary Contract Manufacturing Animal health products and veterinary solutions supporting animal health, productivity, and care through specialized manufacturing capabilities for veterinary and animal health brands.
- Pharmaceutical Product Development and R&D Services R&D and product development services including new formulations, stability testing, and product differentiation, supported by a DSIR-approved research facility for partners seeking customized healthcare solutions.
- Private Label Manufacturing Solutions Manufacturing under partner brands with flexible solutions across multiple product formats including strips, blisters, sachets, pouches, tubes, jars, and roll-ons, for healthcare and wellness brand owners.
Quantifiable outcome
- 350+ companies trust Tirupati for manufacturing and development
- +2 more outcomes
Companies that use Tirupati Group
Customer profileNamed customers2 records
Segments5 records
Ideal customer profiles3 records
Tirupati Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature3 records
Tirupati Group partnerships and signals
Strategic signalScale indicators10 records
Recent moves9 records
Expansion highlights6 records
Tirupati Group competitors and assessment
Company assessmentDirect peers
- Laurus Labs: Indian pharmaceutical company providing CDMO services in APIs and formulations, with growing finished dosage form capabilities comparable to Tirupati's multi-dosage manufacturing.
- Suven Pharmaceuticals: Hyderabad-based CRAMS (Contract Research and Manufacturing Services) company focused on niche API and intermediate development, comparable to Tirupati's CDMO positioning with global pharma clients.
- Syngene International: Bengaluru-based CRO/CDMO providing contract development and manufacturing services to global pharmaceutical and nutraceutical companies, comparable to Tirupati's integrated discovery-to-commercial offering.
- Neuland Laboratories: Indian API and CDMO company offering contract manufacturing services to global pharma, with overlapping capabilities in small-molecule drug substance and drug product manufacturing.
- Sai Life Sciences: Indian CDMO offering API and drug product development and manufacturing services to global pharma and biotech, with similar multi-dosage form capabilities and international regulatory footprint.
- Divis Laboratories: Leading Indian API manufacturer with growing CDMO presence serving global pharma, comparable scale of operations and international regulatory certifications.
- Piramal Pharma Solutions: Indian-headquartered CDMO offering integrated drug development and manufacturing services across solid orals, liquids, and injectables for global pharma partners, directly competing with Tirupati's contract manufacturing model.
- Granules India: Indian pharmaceutical manufacturer specializing in high-volume formulations including tablets, capsules, and APIs for global generics companies, comparable to Tirupati's high-capacity multi-dosage operations.
Emerging players
- Aurigene Pharmaceutical Services: Indian CDMO offering drug substance and drug product development services to global pharma and biotech, with growing capabilities overlapping with Tirupati's integrated CDMO offering.
Broad incumbents
- Jubilant Pharmova: Diversified Indian pharma player with significant CDMO segment offering sterile injectables, APIs, and radiopharmaceuticals, providing a broader benchmark against Tirupati's CDMO operations.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights7 records
Customer concentration
Tirupati Group social profiles
Digital presenceTirupati Group compliance and trust
Trust signalCompliance20 records
Tirupati Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Tirupati Group leadership team
Management profileNumber of profiles
Profiles5 records
Tirupati Group subsidiaries and ownership
Company hierarchySubsidiaries4 records
Tirupati Group funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Tirupati Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Tirupati Group
What does Tirupati Group do?
Tirupati Group is a Contract Development and Manufacturing Organization (CDMO) that provides end-to-end pharmaceutical and nutraceutical manufacturing services to healthcare brands. The company delivers integrated solutions spanning concept development, formulation R&D, regulatory support, and commercial-scale production across multiple dosage forms (tablets, capsules, oral liquids, powders, drops, creams, ointments, and oils) for pharmaceutical, nutraceutical, Ayurveda, sports nutrition, and veterinary segments. Services include contract manufacturing, product development, private label solutions, and commercial scale production for 350+ partner companies globally.
Is Tirupati Group a public or private company?
Tirupati Group is a private company. It is classified as venture growth investor backed and is currently operating.
When was Tirupati Group founded?
Tirupati Group was founded in 2005. It employs 1,001 to 5,000 people.
Where is Tirupati Group based?
Tirupati Group is headquartered in New Delhi, India, in the Asia region.
How does Tirupati Group make money?
Three revenue lines are on record. Contract Manufacturing is the primary driver. The others are product Development Services and private Label Solutions.
Who are Tirupati Group's main competitors?
Direct peers on record are Laurus Labs, Suven Pharmaceuticals, Syngene International, Neuland Laboratories, Sai Life Sciences, Divis Laboratories, Piramal Pharma Solutions and Granules India. Aurigene Pharmaceutical Services is listed as an emerging player. Jubilant Pharmova is listed as a broad incumbent.
Does Tirupati Group have an API?
No public API is recorded for Tirupati Group.
What industry is Tirupati Group in?
Tirupati Group's product category is Pharmaceutical Contract Manufacturing. Its primary akta.pro industry code is HLAGABAB, Small-Molecule Drug Product (Solid/Oral/Parenteral) CDMO, with a secondary code of HLAGABAH, Sterile Fill-Finish & Aseptic Manufacturing CDMO. Its NAICS code is 3254 and its SIC code is 2834.